Hsbc Holdings PLC Exelixis, Inc. Transaction History
Hsbc Holdings PLC
- $168 Billion
- Q4 2024
A detailed history of Hsbc Holdings PLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 9,088 shares of EXEL stock, worth $350,615. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,088
Previous 27,126
66.5%
Holding current value
$350,615
Previous $703,000
57.04%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding EXEL
# of Institutions
566Shares Held
251MCall Options Held
1.45MPut Options Held
1.13M-
Black Rock Inc. New York, NY33.5MShares$1.29 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.14 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$904 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$590 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$440 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.4B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...